Articles

RSS

Billerica, MA - Millipore Corporation , a leading provider of technologies, tools and services for the global life science industry, recently announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.

"Combining Millipore's expertise in purification with Dow's extensive experience in ion-exchange resins technology allows us to offer biopharmaceutical manufacturers a substantially expanded chromatography solution," said Paul Chapman, Vice President of Millipore's Downstream Processing Business Unit. "ProRes-S media brings the biomanufacturing industry increased efficiencies to their purification process."

ProRes-S media, a semirigid cation exchange resin, offers a broader operating window over a wider range of conductivities, is optimized for resolving difficult impurities and allows higher bed packing. To learn more about ProRes-S media, visit www.millipore.com/prores.

SOURCE: Millipore Corporation